Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 20, 2013

Amarin, Bristol-Myers Squibb, Cellceutix, FibroGen, MicuRx, Pfizer, Ultragenyx

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II FibroGen begins IPF trial enrollment . . . read more MicuRx expands antibiotic program . . . read more Ultragenyx posts topline results in HIBM trial . . . read more Filings Amarin sNDA review delayed . . . read more Cellceutix files for Orphan designation for mucositis treatment . . . read more Eliquis sNDA Accepted by FDA . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters